Specialist Investor
Differentiated approach
Enabling world-class leadership teams to succeed on the global stage
Global Healthcare Opportunities
Better, Faster + More Accessible HealthcareTM
Embedded
in healthcare
Updates
- GHO Capital invests in Sapio Sciences, a leading, high growth lab informatics platform companySapio has established a unique, highly scalable, best in class lab informatics platform with multiple avenues for growth and expansionStrongly positioned to address an international, high growth market demanding new data-driven and fit for purpose AI assisted lab informatics technologiesGHO combines its deep life science market knowledge, network and expertise…
- Biocare Medical Acquires Empire Genomics, Expanding Molecular Portfolio to over 1 Million Biomarkers and Adding Rapid Biomarker Development to Lead Cancer ResearchLondon, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, acknowledges the announcement from its portfolio company Biocare Medical, regarding its acquisition of Empire Genomics. Biocare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) and FISH (Fluorescent in situ hybridisation) instrumentation…
- Velocity Clinical Research expands to UKLondon, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, acknowledges the announcement from its portfolio company Velocity Clinical, regarding its expansion into the UK. Velocity Clinical Research (“Velocity”), the leading integrated research site organisation, announced its expansion into the UK with the acquisition…
